Literature DB >> 9377532

Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: Changes under nCPAP treatment.

I Fietze1, S Quispe-Bravo, T Hänsch, J Röttig, G Baumann, C Witt.   

Abstract

Nocturnal arousals are the essential cause of disturbed sleep structure in patients with obstructive sleep apnoea syndrome (OSAS). The aim of this study was to analyse the relationship between sleep stages, respiratory (type-R) and movement (type-M) related EEG arousals. Furthermore, the value of these arousals as a criterion for the efficiency of nCPAP treatment was estimated. We examined 38 male patients aged between 30 and 71 (49.1 +/- 20.9 SD) y. All patients suffered from OSAS. The mean respiratory disturbance index (RDI) was 47.3 +/- 27.8 per h. Polysomnographic monitoring was carried out on 4 subsequent nights: baseline night, 2 nights of nCPAP titration and nCPAP control night. Sleep was visually scored and EEG arousals were classified into type R and M, depending on whether changes of respiration or movement caused the arousal. The RDI, the R index (type-R/h), the M index (type-M/h) and the R and M indices in different sleep stages were calculated. During the baseline night a deficit of slow wave sleep (SWS) and REM sleep was found. Furthermore there were more type-R than type-M arousals registered (17.4 h-1 [3.6-43.6] vs. 5.9 h-1 [1.6-11.8]) (P < 0.01). They occurred during stages NREM 1, NREM 2 and REM (P < 0.01). An SWS sleep rebound and a reduction of the SWS and REM latencies were already found during the first CPAP night. The R index was reduced during the first CPAP night in all sleep stages (P < 0.01) and remained approximately the same in the following 2 nights (3. CPAP night: 1.1 h-1 [0.3-5.0]). Type M arousals occurred more in stages 1 and 2 (P < 0.01), and remained unchanged under nCPAP. We concluded that differentiation of nocturnal arousals may provide more detailed information regarding the influence of breathing disturbances on sleep. Respiratory related, not movement related, arousals may be a useful additional tool in judging the efficiency of OSAS.

Entities:  

Mesh:

Year:  1997        PMID: 9377532     DOI: 10.1046/j.1365-2869.1997.00029.x

Source DB:  PubMed          Journal:  J Sleep Res        ISSN: 0962-1105            Impact factor:   3.981


  13 in total

1.  The Odds Ratio Product (An Objective Sleep Depth Measure): Normal Values, Repeatability, and Change With CPAP in Patients With OSA.

Authors:  Charles Gerhard Penner; Bethany Gerardy; Rob Ryan; Mark Williams
Journal:  J Clin Sleep Med       Date:  2019-08-15       Impact factor: 4.062

Review 2.  Sleep and metabolic function.

Authors:  Lisa L Morselli; Aurore Guyon; Karine Spiegel
Journal:  Pflugers Arch       Date:  2011-11-19       Impact factor: 3.657

3.  Effects of upper-airway stimulation on sleep architecture in patients with obstructive sleep apnea.

Authors:  Benedikt Hofauer; Pierre Philip; Markus Wirth; Andreas Knopf; Clemens Heiser
Journal:  Sleep Breath       Date:  2017-05-31       Impact factor: 2.816

Review 4.  Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology.

Authors:  Anna E Mullins; Korey Kam; Ankit Parekh; Omonigho M Bubu; Ricardo S Osorio; Andrew W Varga
Journal:  Neurobiol Dis       Date:  2020-08-27       Impact factor: 5.996

5.  A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea.

Authors:  Ian M Colrain; Stephen Brooks; Jed Black
Journal:  J Clin Sleep Med       Date:  2008-10-15       Impact factor: 4.062

6.  Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Inger Hilde Nordhus; Bjørn Bjorvatn
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

7.  Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea.

Authors:  Jana R Cooke; Sonia Ancoli-Israel; Lianqi Liu; Jose S Loredo; Loki Natarajan; Barton S Palmer; Feng He; Jody Corey-Bloom
Journal:  Sleep Med       Date:  2009-08-20       Impact factor: 3.492

8.  Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea.

Authors:  Ariel B Neikrug; Lianqi Liu; Julie A Avanzino; Jeanne E Maglione; Loki Natarajan; Lenette Bradley; Alex Maugeri; Jody Corey-Bloom; Barton W Palmer; Jose S Loredo; Sonia Ancoli-Israel
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

9.  Long-term CPAP treatment partially improves the link between cardiac vagal influence and delta sleep.

Authors:  Fabrice Jurysta; Chantal Kempenaers; Jean-Pol Lanquart; André Noseda; Philippe van de Borne; Paul Linkowski
Journal:  BMC Pulm Med       Date:  2013-04-30       Impact factor: 3.317

10.  Impact of acetazolamide and CPAP on cortical activity in obstructive sleep apnea patients.

Authors:  Katrin Stadelmann; Tsogyal D Latshang; Yvonne Nussbaumer-Ochsner; Leila Tarokh; Silvia Ulrich; Malcolm Kohler; Konrad E Bloch; Peter Achermann
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.